Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment ; volume:9 ; number:1 ; year:2019 ; pages:100-113
Dementia and geriatric cognitive disorders / Extra. Extra ; 9, Heft 1 (2019), 100-113

Urheber
Park, Jung Eun
Choi, Kyu Yeong
Kim, Byeong C.
Choi, Seong-Min
Song, Min-Kyung
Lee, Jang Jae
Kim, Jahae
Song, Ho-Chun
Kim, Hoo-Won
Ha, Jung-Min
Seo, Eun Hyun
Song, Woo Keun
Park, Sung-Gyoo
Lee, Jung Sup
Lee, Kun Ho

DOI
10.1159/000496920
URN
urn:nbn:de:101:1-2019061300170025569562
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:55 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Park, Jung Eun
  • Choi, Kyu Yeong
  • Kim, Byeong C.
  • Choi, Seong-Min
  • Song, Min-Kyung
  • Lee, Jang Jae
  • Kim, Jahae
  • Song, Ho-Chun
  • Kim, Hoo-Won
  • Ha, Jung-Min
  • Seo, Eun Hyun
  • Song, Woo Keun
  • Park, Sung-Gyoo
  • Lee, Jung Sup
  • Lee, Kun Ho

Ähnliche Objekte (12)

EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features

EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features

A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease

A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

Brainstem substructures and cognition in prodromal Alzheimer’s disease

Brainstem substructures and cognition in prodromal Alzheimer’s disease

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease

Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease

Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians

Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers

Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers

Verbundene Objekte